CoreValve, Inc.: Series C Series C $33M

CoreValve (Irvine, CA) is a medical device company introducing a percutaneous revalving system to replace failing aortic heart valves without surgical access closed a $33M Series C financing. The deal was led by Maverick Capital other participants included Apax Partners, HealthCap and Sofinnova Partners.

Transoma Medical, Inc.: Series C $13M

Transoma Medical (St. Paul, MN) maker of implantable wireless monitoring systems for patients with chronic cardiovascular disease closed a $13M Series C financing. The deal was led by Canaan Partners, Affinity Capital Management and Polaris Venture Partners.

CircuLite, Inc.: Series B $20M

CicuLite (Hackensack, NJ) a medical device company focused on the development of a proprietary circulatory assist technology for the management of chronic heart failure, closed a $20M Series B. Investors included Forbion Capital Partners, Oxford Biosciences Partners, Foundation Medical Partners, and SB Life Science Ventures.

iRhythm Tech, Inc.: Series A $12.5M

iRhythm Technologies (San Francisco, CA) is developing a next-generation cardiac-rhythm monitoring device has raised a Series A financing of $12.5M from Mohr Davidow Ventures and Synergy Venture Partners.

InnerPulse, Inc.: Series C $50M

InnerPulse (Research Triangle Park, NC) a developer of implantable defibrillators raised $50M in a Series C financing. Investors included Johnson & Johnson Development Corp., Medtronic, Synergy Life Science Partners, Ascent Biomedical Ventures, Delphi Ventures and Frazier Healthcare Ventures.

Ovalis, Inc.: Series B $6.6M

Ovalis (Mountain View, CA) a developer of catheter-based products for repairing cardiac defects, has raised around $6.6 million in Series B funding. Return backers include Abbott Labs, De Novo Ventures and Latterell Venture Partners.